Outcome of Standard Induction Therapy With Daunorubicin and Ara-C (3+7) in Acute Myeloid Leukemia. J Dhaka Med Coll 2016, 24 (2), 141-145. https://doi.org/10.3329/jdmc.v24i2.29626.